Next Article in Journal
Targeted Complement Treatments in Glomerulopathies: A Comprehensive Review
Previous Article in Journal
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers
 
 
Article

Article Versions Notes

J. Clin. Med. 2025, 14(3), 703; https://doi.org/10.3390/jcm14030703
Action Date Notes Link
article xml file uploaded 22 January 2025 11:41 CET Original file -
article xml uploaded. 22 January 2025 11:41 CET Update https://www.mdpi.com/2077-0383/14/3/703/xml
article pdf uploaded. 22 January 2025 11:41 CET Version of Record https://www.mdpi.com/2077-0383/14/3/703/pdf
article html file updated 22 January 2025 11:42 CET Original file https://www.mdpi.com/2077-0383/14/3/703/html
Back to TopTop